{"entity":{"type":"insider","cik":"0001824673","url":"/insider/0001824673","json_url":"/insider/0001824673.json","name":"McNeill Jonathan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":35,"n_filings":19,"first":"2021-09-22","last":"2026-06-23","span_basis":"filed_date"},"name_variants":[{"name":"McNeill Jonathan","source":"filing","n_filings":19,"first_seen":"2021-09-22","last_seen":"2026-06-23"}],"transactions":[{"id":6173750,"accession":"0001628280-26-044885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-044885","line_url":"/filing/0001628280-26-044885#line-1","is_derivative":false,"issuer_cik":"0001253689","issuer_name":"CRESCENT BIOPHARMA, INC.","issuer_ticker":"CBIO","issuer_name_source":null,"issuer_url":"/issuer/0001253689","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (President and COO)","role_mark":"O","role_mark_label":"Officer (President and COO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20549.0,"shares_display":"20,549","price_per_share":17.99,"price_display":"17.99","price_state":"stated","total_value":369676.51,"total_display":"369,676.51","total_whole":"369,677","shares_owned_after":139158.0,"shares_owned_after_display":"139,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-23","scope":"insider"},{"id":2772124,"accession":"0000950170-24-099127","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-099127","line_url":"/filing/0000950170-24-099127","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2705.0,"shares_display":"2,705","price_per_share":45.121626617375235,"price_display":"45.12","price_state":"stated","total_value":122054.0,"total_display":"122,054.00","total_whole":"122,054","shares_owned_after":132411.0,"shares_owned_after_display":"132,411","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2237086,"accession":"0000950170-24-072151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-072151","line_url":"/filing/0000950170-24-072151#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1823.0,"shares_display":"1,823","price_per_share":31.34,"price_display":"31.34","price_state":"stated","total_value":57132.82,"total_display":"57,132.82","total_whole":"57,133","shares_owned_after":134811.0,"shares_owned_after_display":"134,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider"},{"id":2677250,"accession":"0000950170-24-062075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-062075","line_url":"/filing/0000950170-24-062075","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2774.0,"shares_display":"2,774","price_per_share":28.269592645998557,"price_display":"28.27","price_state":"stated","total_value":78419.85,"total_display":"78,419.85","total_whole":"78,420","shares_owned_after":137129.0,"shares_owned_after_display":"137,129","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2768225,"accession":"0000950170-24-030484","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000950170-24-030484","line_url":"/filing/0000950170-24-030484","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19601.0,"shares_display":"19,601","price_per_share":25.500839753073823,"price_display":"25.50","price_state":"stated","total_value":499841.96,"total_display":"499,841.96","total_whole":"499,842","shares_owned_after":141184.0,"shares_owned_after_display":"141,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider","n_lines":2},{"id":2768208,"accession":"0000950170-24-030484","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950170-24-030484","line_url":"/filing/0000950170-24-030484","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90000.0,"shares_display":"90,000","price_per_share":26.239234777777778,"price_display":"26.24","price_state":"stated","total_value":2361531.13,"total_display":"2,361,531.13","total_whole":"2,361,531","shares_owned_after":141873.0,"shares_owned_after_display":"141,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-08","filed_date":"2024-03-13","scope":"insider","n_lines":3},{"id":3109073,"accession":"0000950170-24-029607","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-029607","line_url":"/filing/0000950170-24-029607#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2434.0,"shares_display":"2,434","price_per_share":25.85,"price_display":"25.85","price_state":"stated","total_value":62918.9,"total_display":"62,918.90","total_whole":"62,919","shares_owned_after":141184.0,"shares_owned_after_display":"141,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider"},{"id":2203762,"accession":"0000950170-24-024299","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-024299","line_url":"/filing/0000950170-24-024299","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24260.0,"shares_display":"24,260","price_per_share":28.627166117065126,"price_display":"28.63","price_state":"stated","total_value":694495.05,"total_display":"694,495.05","total_whole":"694,495","shares_owned_after":153775.0,"shares_owned_after_display":"153,775","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-01","scope":"insider","n_lines":3},{"id":2203749,"accession":"0000950170-24-024299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-024299","line_url":"/filing/0000950170-24-024299#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4268.0,"shares_display":"4,268","price_per_share":27.5,"price_display":"27.50","price_state":"stated","total_value":117370.0,"total_display":"117,370.00","total_whole":"117,370","shares_owned_after":143618.0,"shares_owned_after_display":"143,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-01","scope":"insider"},{"id":2892363,"accession":"0000950170-24-008062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-008062","line_url":"/filing/0000950170-24-008062","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":24.525518,"price_display":"24.53","price_state":"stated","total_value":490510.36,"total_display":"490,510.36","total_whole":"490,510","shares_owned_after":143796.0,"shares_owned_after_display":"143,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-26","scope":"insider","n_lines":2},{"id":2340463,"accession":"0000950170-24-002278","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000950170-24-002278","line_url":"/filing/0000950170-24-002278#line-6","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2009.0,"shares_display":"2,009","price_per_share":18.04,"price_display":"18.04","price_state":"stated","total_value":36242.36,"total_display":"36,242.36","total_whole":"36,242","shares_owned_after":143618.0,"shares_owned_after_display":"143,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-04","scope":"insider"},{"id":2340453,"accession":"0000950170-24-002278","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-002278","line_url":"/filing/0000950170-24-002278","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17991.0,"shares_display":"17,991","price_per_share":18.735030848757713,"price_display":"18.74","price_state":"stated","total_value":337061.94,"total_display":"337,061.94","total_whole":"337,062","shares_owned_after":143618.0,"shares_owned_after_display":"143,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-04","scope":"insider","n_lines":2},{"id":2340440,"accession":"0000950170-24-002278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-002278","line_url":"/filing/0000950170-24-002278#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11900.0,"shares_display":"11,900","price_per_share":13.1,"price_display":"13.10","price_state":"stated","total_value":155890.0,"total_display":"155,890.00","total_whole":"155,890","shares_owned_after":143618.0,"shares_owned_after_display":"143,618","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-02","filed_date":"2024-01-04","scope":"insider"},{"id":8609759,"accession":"0001209191-23-058330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058330","line_url":"/filing/0001209191-23-058330#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1245.0,"shares_display":"1,245","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":13346.4,"total_display":"13,346.40","total_whole":"13,346","shares_owned_after":155518.0,"shares_owned_after_display":"155,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8726875,"accession":"0001209191-23-050173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050173","line_url":"/filing/0001209191-23-050173#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1261.0,"shares_display":"1,261","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":11866.01,"total_display":"11,866.01","total_whole":"11,866","shares_owned_after":60605.0,"shares_owned_after_display":"60,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-20","scope":"insider"},{"id":7899411,"accession":"0001209191-23-049360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049360","line_url":"/filing/0001209191-23-049360#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1266.0,"shares_display":"1,266","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":13179.06,"total_display":"13,179.06","total_whole":"13,179","shares_owned_after":61866.0,"shares_owned_after_display":"61,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8545701,"accession":"0001209191-23-037167","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-037167","line_url":"/filing/0001209191-23-037167#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1259.0,"shares_display":"1,259","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":15649.37,"total_display":"15,649.37","total_whole":"15,649","shares_owned_after":63132.0,"shares_owned_after_display":"63,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":8545697,"accession":"0001209191-23-037167","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037167","line_url":"/filing/0001209191-23-037167#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":13000.0,"total_display":"13,000.00","total_whole":"13,000","shares_owned_after":64391.0,"shares_owned_after_display":"64,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-14","scope":"insider"},{"id":8437486,"accession":"0001209191-23-018981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-018981","line_url":"/filing/0001209191-23-018981#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1209.0,"shares_display":"1,209","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":16115.97,"total_display":"16,115.97","total_whole":"16,116","shares_owned_after":65391.0,"shares_owned_after_display":"65,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":8437481,"accession":"0001209191-23-018981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018981","line_url":"/filing/0001209191-23-018981#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":13000.0,"total_display":"13,000.00","total_whole":"13,000","shares_owned_after":66600.0,"shares_owned_after_display":"66,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-13","filed_date":"2023-03-15","scope":"insider"},{"id":8182524,"accession":"0001209191-23-004345","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-004345","line_url":"/filing/0001209191-23-004345#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.03,"price_display":"14.03","price_state":"stated","total_value":140300.0,"total_display":"140,300.00","total_whole":"140,300","shares_owned_after":67600.0,"shares_owned_after_display":"67,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-18","filed_date":"2023-01-23","scope":"insider"},{"id":8287251,"accession":"0001209191-23-003013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003013","line_url":"/filing/0001209191-23-003013#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30150.0,"shares_display":"30,150","price_per_share":11.57,"price_display":"11.57","price_state":"stated","total_value":348835.5,"total_display":"348,835.50","total_whole":"348,836","shares_owned_after":67600.0,"shares_owned_after_display":"67,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6213626,"accession":"0001209191-22-060972","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060972","line_url":"/filing/0001209191-22-060972#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":472.0,"shares_display":"472","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":5130.64,"total_display":"5,130.64","total_whole":"5,131","shares_owned_after":97750.0,"shares_owned_after_display":"97,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6845935,"accession":"0001209191-22-018536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018536","line_url":"/filing/0001209191-22-018536#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":481.0,"shares_display":"481","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":4199.13,"total_display":"4,199.13","total_whole":"4,199","shares_owned_after":60466.0,"shares_owned_after_display":"60,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":4435375,"accession":"0001209191-21-057325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-057325","line_url":"/filing/0001209191-21-057325#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":16.11,"price_display":"16.11","price_state":"stated","total_value":11744.19,"total_display":"11,744.19","total_whole":"11,744","shares_owned_after":35636.0,"shares_owned_after_display":"35,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":4435369,"accession":"0001209191-21-057325","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057325","line_url":"/filing/0001209191-21-057325#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001824673","owner_name":"McNeill Jonathan","owner_display_name":"McNeill Jonathan","owner_url":"/insider/0001824673","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":545.0,"shares_display":"545","price_per_share":15.61,"price_display":"15.61","price_state":"stated","total_value":8507.45,"total_display":"8,507.45","total_whole":"8,507","shares_owned_after":36365.0,"shares_owned_after_display":"36,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-20","filed_date":"2021-09-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":35,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":35,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":35},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001253689","name":"CRESCENT BIOPHARMA, INC.","url":"/issuer/0001253689","role":"Officer (President and COO)","n_filings":1,"first_seen":"2026-06-23","last_seen":"2026-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Business Officer)","n_filings":18,"first_seen":"2021-09-22","last_seen":"2024-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001824673","retrieved_at":"2026-08-24T16:47:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}